News
Beckley psychedelic hits the target, unlocking atai merger
UK psychedelic medicines developer Beckley Psytech is preparing to …
21700 items found
Oncology
News
Barriers are limiting UK childhood vaccination, say doctors
Parents in the UK are being blocked from arranging routine …
News
New medicine access times to be slashed under NHS plan
A new task force comprising staff from the UK medicines regulator, …
News
Amgen's Five Prime takeover delivers gastric cancer win
Four years after buying Five Prime for $1.9 billion, Amgen has …
News
AbbVie's $2.1bn buy of Capstan lifts its immunology pipeline
AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, …
R&D
Changing Faces – Pharma and biotech hires – May 2025
The pharmaceutical and biotechnology sectors witnessed significant …
R&D
GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders
GRIN-related neurodevelopmental disorder (GRIN-NDD) is a family of …
Oncology
The Leukemia & Lymphoma Society at ASCO 2025: Blood cancers and future oncological trends
ASCO 2025 spotlighted new data across haematologic cancers this year. …
News
Moderna shines spotlight on new flu vaccine data
Moderna may be facing regulatory uncertainty in the US for its …
News
INmune Bio slumps on midstage fail for Alzheimer's drug
Shares in INmune Bio lost almost two-thirds of their value in …
News
Generic drugmaker Hikma pledges $1bn in US investment
Faced with the prospect of tariffs on imported medicines threatened …
Digital
FH25: Jessica DaMassa on hosting, hype, and health innovatio...
In a new episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with WTF Health founder and event emcee, Jessica DaMassa
Digital
Sponsored
Tracking studies get smarter: AI meets human intelligence
Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market
Market Access
12 questions with: Daniel Kohlstaedt
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
Digital
Sponsored
Future proofing production: Implementing AI in pharmaceutica...
Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.
Digital
Agentic AI buoys all stakeholders in oncology, with Eron Kel...
At LSX 2025, Eron Kelly, CEO of Concert AI, discussed the work his Boston-based start-up is doing in oncology.
R&D
Life Sciences Industry Report - Rare Disease Space
There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.
Digital
Partner Content
Axtria and Kedaara Capital Announce Strategic $240 Million I...
The transaction delivers total liquidity of $240 million, making it one of the largest employee-centric liquidity events in the industry.
R&D
Partner Content
4th LNP Immunogenicity & Toxicity Summit
Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines